Contraceptive Choice at the Time of Uterine Evacuation

NCT ID: NCT02836561

Last Updated: 2017-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

234 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this project is to investigate whether a pre-visit telephone intervention could increase awareness of long-acting reversible contraception (LARC) availability at the time of uterine evacuation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Message

Participants who are randomized to the intervention message will receive contraception information in advance of their appointment that may be helpful in their decision-making.

Group Type EXPERIMENTAL

Telephone message

Intervention Type OTHER

A pre-visit telephone intervention describing availability of long-acting reversible contraceptives at time of uterine evacuation

Control Message

Participants who are randomized to the control message will receive appointment logistic information that may be a helpful reminder.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telephone message

A pre-visit telephone intervention describing availability of long-acting reversible contraceptives at time of uterine evacuation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or older
* Scheduled for uterine evacuation
* Speaks English proficiently in order to understand the telephone conversation and the survey questions.

Exclusion Criteria

* Previous participation in this study
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Planned Parenthood League of Massachusetts

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Principal Investigator, MD

Role: PRINCIPAL_INVESTIGATOR

Planned Parenthood League of Massachusetts

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Planned Parenthood League of Massachusetts

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Roe AH, Fortin J, Gelfand D, Janiak E, Maurer R, Goldberg A. Advance notice of contraceptive availability at surgical abortion: a pilot randomised controlled trial. BMJ Sex Reprod Health. 2018 Jul;44(3):187-192. doi: 10.1136/bmjsrh-2017-200023. Epub 2018 May 18.

Reference Type DERIVED
PMID: 30012721 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016P000619

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Long-Acting Reversible Contraception
NCT01299116 COMPLETED PHASE4
Quick Start of Highly Effective Contraception
NCT02076217 ACTIVE_NOT_RECRUITING
Contraceptive Choice Center
NCT02633631 COMPLETED